Aronson Martha Goldberg
Aronson Martha Goldberg's purchase track record
Aronson Martha Goldberg has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/6/2026 | MMSI | $121K | +41.5% | pending | — |
| 5/6/2024 | CNMD | $142K | -7.0% | +0.1% | +10.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CNMD Featured in Low-Volatility Stock List. Conmed was included in a recent Yahoo Finance article highlighting three low-volatility stocks with questionable fundamentals. The piece suggests that while the stock may exhibit stable price movements, underlying financial metrics warrant closer scrutiny. This context is relevant for investors assessing the balance between the company's current valuation and its operational stability.
Transaction History
| MMSI | ▲ Buy | Open Market | 2,000 | $121K | 5/6/2026 | View on chart |
| MMSI | ▲ Buy | Grant | 28,198 | $0 | 2/26/2026 | View on chart |
| MMSI | ▲ Buy | Grant | 19,594 | $0 | 10/3/2025 | View on chart |
| CNMD | ▲ Buy | Option Exercise | 479 | $0 | 6/3/2025 | View on chart |
| CNMD | ▲ Buy | Option Exercise | 302 | $0 | 5/31/2024 | View on chart |
| CNMD | ▲ Buy | Open Market | 2,000 | $142K | 5/6/2024 | View on chart |
| CNMD | ▲ Buy | Option Exercise | 335 | $0 | 6/1/2023 | View on chart |
| CNMD | ▲ Buy | Option Exercise | 812 | $0 | 6/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Merit Medical Systems sets Q3 2026 earnings date
Merit Medical Systems announced it will report its third-quarter 2026 results on October 29, 2026. This upcoming earnings date is the primary catalyst for the stock, as investors await fresh financial updates. The company is currently trading within its 52-week range, with an average analyst target price of $101.45.
Merit Medical Systems sets Q3 2026 earnings date. Merit Medical Systems announced it will report its third-quarter 2026 results on October 29, 2026. This upcoming earnings date is the primary catalyst for the stock, as investors await fresh financial updates. The company is currently trading within its 52-week range, with an average analyst target price of $101.45.